WA
IDXX icon

Winfield Associates’s Idexx Laboratories IDXX Stock Holding History

Winfield Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50
Closed -$8K – 357
2017
Q4 		$8K Hold
50
– – ﹤0.01% 452
2017
Q3 		$8K Hold
50
– – ﹤0.01% 434
2017
Q2 		$8K Hold
50
– – ﹤0.01% 436
2017
Q1 		$8K Hold
50
– – ﹤0.01% 412
2016
Q4 		$6K Hold
50
– – ﹤0.01% 407
2016
Q3 		$6K Hold
50
– – ﹤0.01% 387
2016
Q2 		$5K Buy
50
+40
+400% +$3.44K ﹤0.01% 400
2016
Q1 		$1K Buy
+10
New +$720 ﹤0.01% 591

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Winfield Associates's IDXX Position: Q1 2018 in Review

Winfield Associates sold out of Idexx Laboratories (IDXX) in Q1 2018, closing a stake of 50 shares — an estimated $8K sold.

Winfield Associates first reported a position in IDXX in Q1 2016 and held it in 8 quarters. The position peaked at $8K in Q4 2017. 646 funds tracked by Wall St. Rank hold IDXX as of Q1 2018.

  • Winfield Associates reported no remaining Idexx Laboratories position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 50 Idexx Laboratories shares in Q1 2018, an estimated $8K.
  • Winfield Associates first reported a position in Idexx Laboratories in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Idexx Laboratories position peaked at $8K in Q4 2017.
  • 646 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.